AstraZeneca disclosed Wednesday that Leon Wang, a high-ranking executive who oversees international operations and is also president of its subsidiary in China, is under investigation by Chinese ...

The president of AstraZeneca’s China division has been placed under investigation by local police, as Beijing advances an anti-corruption crackdown in the healthcare sector. The British ...

AstraZeneca’s China president is under investigation in mainland China, the drug company said on Wednesday. Leon Wang was described as cooperating “with an ongoing investigation”, the ...

BEIJING - The head of multinational pharmaceutical giant AstraZeneca’s China arm is under investigation in the country, the firm said. Mr Leon Wang, president of AstraZeneca China, is ...

British-Swedish drugmaker AstraZeneca confirmed on Wednesday that its China President Leon Wang is under investigation by Chinese authorities, marking the latest probe into the pharmaceutical ...

BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-0.18%decrease; red down pointing triangle is the latest to rattle foreign companies in China, where a series of ...

Covid vaccine compensation could be given to thousands left 'disabled' by the AstraZeneca jab, it has emerged. Health Secretary Wes Streeting is understood to be considering plans to set up a ...

A Covid vaccine compensation scheme could be set up after thousands claimed they have been left disabled as a result of the AstraZeneca jab, The Telegraph has learnt. The Health Secretary is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

UK pharmaceutical giant AstraZeneca has entered into an exclusive license agreement with China's CSPC Pharmaceutical Group (CSPC) to advance the development of an early stage, novel small molecule ...

Oct 7 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd (1093.HK), opens new tab in an exclusive licence agreement to ...